NRC Health appoints Linda Stacy as PFO; Q1 dividend $0.12; $40M net debt; no GAAP results disclosed

NRC HEALTH

2024-Q1 EPS reported $0.27 revenue$35,313,000

Linda Stacy appointed Principal Financial Officer effective May 7, 2024; retains roles as PAAO and Secretary.
Quarterly cash dividend of $0.12/share declared, payable July 15, 2024 to holders of record June 28, 2024.
Q1 2024 returned $18M to stockholders via dividends and share repurchases; $4M invested in innovation.
Net debt ~$40M; available liquidity includes $23M line of credit and $56M delayed draw term facility.
Press release provides no GAAP revenue or EPS figures; CEO cites upcoming AI features and expanded product suite.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Linda Stacy

Principal Financial Officer

NRC · NRC HEALTH

Effective: 2024-05-07
Filed: May 7, 2024, 7:59 PM ET

On May 7, 2024, the Company’s Board of Directors appointed Linda Stacy as the Company’s Principal Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Linda Stacy was appointed as Principal Financial Officer at NRC HEALTH.

Action: appointed
Role: Principal Financial Officer

Exact text from the filing

On May 7, 2024, the Company’s Board of Directors appointed Linda Stacy as the Company’s Principal Financial Officer.

View on SEC.gov

NRC HEALTH filing history →

Source: SEC EDGAR

accession 0001437749-24-015131

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.